It is worth mentioning that, celastrol plays a role in inhibiting PI3K/AKT signaling pathway in the treatment of various diseases, such as glioblastoma and prostate cancer (Pang et al., 2010; Kannaiyan et al., 2011). Here, AKT1 is linked to prostate cancer.